Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for mitomycin c
Most Correlated Studies
- HepG2 cells treated with genotoxic and non-genotoxic agents
- N/Tert-1 foreskin keratinocytes expressing HPV E6 proteins treated with mitomycin C
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
- L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
- Diffuse Large B-Cell Lymphoma OCI-LY3 cells time-course/dose response treatment with 14 drug panel
Most Relevant Literature
- RETINAL TOXICITY SECONDARY TO INADVERTENT SUBRETINAL MITOMYCIN C INJECTION.
- Stability of refractive outcomes after hyperopic LASIK with and without Mitomycin C application: a r…
- Proteomic Profiling of Endothelial Cells Exposed to Mitomycin C: Key Proteins and Pathways Underlyin…
- Revision of the PRESERFLO® MicroShunt with ologen and mitomycin C].
- Use of Mitomycin-C in Laryngotracheal Stenosis: A Focused Clinical Review.
Most Relevant Clinical Trials
- The Effectiveness and Safety of Neoadjuvant Intravesical Mitomycin-C Instillation
- Mitomycin C With Hyperthermia and Intravesical Mitomycin C to Treat Recurrent Bladder Cancer
- A Study of Mitomycin C, Irinotecan, and Cetuximab
- Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix
- Comparison Between Topical Mitomycin C and Cyclosporine
